Mission Produce reaffirms second-half fiscal 2026 Adjusted EBITDA outlook of $84 million-$88 million
Bitget2026/10/08 12:20Mission Produce reaffirmed fiscal 2026 second-half Adjusted EBITDA of $84 million-$88 million, including fourth-quarter Adjusted EBITDA of $52 million-$55 million. Second-half Mission Peru exportable volume outlook held at 120 million-130 million pounds, including 67 million-77 million pounds in the fourth quarter. Five-year targets call for mid-single-digit organic sales growth, roughly 300 basis points of margin expansion, cash conversion above 90% of Adjusted Net Income. Framework assumes high-single-digit organic Adjusted EBITDA growth over five years, supported by Calavo synergies and higher asset utilization. Annualized Calavo synergy target raised to more than $30 million from at least $25 million, with a small fiscal Q4 2026 contribution expected. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mission Produce Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001802974-26-000046), on October 08, 2026, and is solely responsible for the information contained therein.
- Mission Produce reaffirmed fiscal 2026 second-half Adjusted EBITDA of $84 million-$88 million, including fourth-quarter Adjusted EBITDA of $52 million-$55 million.
- Second-half Mission Peru exportable volume outlook held at 120 million-130 million pounds, including 67 million-77 million pounds in the fourth quarter.
- Five-year targets call for mid-single-digit organic sales growth, roughly 300 basis points of margin expansion, cash conversion above 90% of Adjusted Net Income.
- Framework assumes high-single-digit organic Adjusted EBITDA growth over five years, supported by Calavo synergies and higher asset utilization.
- Annualized Calavo synergy target raised to more than $30 million from at least $25 million, with a small fiscal Q4 2026 contribution expected.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy
Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized
BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.
AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review
Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).
4 Big Bank Earnings to Watch This Week as Wall Street Turns Bullish
Crypto prices
More
